Company / Net Income
Progyny Net Income History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$58.5M
FY2025
5-year range
$30.4M / $65.8M
FY2021-FY2025
Trend
+7.7%
vs FY2024
Sector context
#73 of 158
Health Care
What the data says
At $59M, Progyny's net income ranks #73 of 158 in the Health Care sector. Net Income has fluctuated over the past 9 years, ranging from -$12M in FY2017 to $66M in FY2021.
Based on SEC 10-K filings.
$59M in FY2025 with a 5-year CAGR of +4.7%.
Declined from $62M to $59M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- +24.5%
- 5-Year CAGR
- +4.7%
- 10-Year CAGR
- -
Sector benchmark
#73 of 158 in Health CareTop 46% of 158This company $58.5M Sector average $458.6M
▼
-87.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.7%, indicating consistent growth.
- In FY2025, net income increased 7.7% year-over-year.
- Ranks #73 out of 158 companies in the Health Care sector.
- Peak net income was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $58.5M | +7.7% |
| FY2024 | $54.3M | -12.4% |
| FY2023 | $62.0M | +104.4% |
| FY2022 | $30.4M | -53.8% |
| FY2021 | $65.8M | +41.6% |
| FY2020 | $46.5M | +642.2% |
| FY2019 | -$8.6M | -1396.4% |
| FY2018 | $661.0K | +105.3% |
| FY2017 | -$12.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026